Fortrea Holdings Reports Q3 Revenue of $691.5 Million

The company saw a 1.4% revenue decline compared to the previous year for the third quarter of 2026.

Updated on Oct. 29, 2026 in Corporate Finance

Isometric editorial illustration of a heavy-duty shipping container, representing the scale and structure of corporate financial reporting. — Fortrea Holdings Inc. reported $691.5 million in revenue for the third quarter of 2026, marking a 1.4% year-over-year decline for the firm. AI Illustration. Upload story photo >

Live Poll

Does a decline in quarterly revenue decrease your trust in a company's long-term financial stability?

Fortrea Holdings Inc. reported $691.5 million in revenue for the third quarter of 2026. This figure represents a 1.4% decrease in revenue compared to the same period in the prior year.

Why it matters

The report provides transparency into the financial performance of the firm as it navigates the 2026 fiscal year. Shareholders use these quarterly figures to gauge operational stability and the accuracy of the company’s full-year financial projections.

Fortrea Holdings Inc. reported non-GAAP earnings of 28 cents per share for the quarter. The company also set its 2026 annual revenue forecast between $2.665 billion and $2.690 billion.

The players

Fortrea Holdings Inc.

Fortrea Holdings Inc. is a contract research organization that provides clinical trial management and consulting services to the pharmaceutical and biotechnology industries.

The details

The firm also issued an adjusted EBITDA forecast for the full 2026 year ranging from $210 million to $218 million. These metrics offer a look at the company's current earnings capacity and future expectations for the remainder of the year.

The financial results cover the third quarter of 2026.
The company's financial outlook spans the full 2026 calendar year.

Market Landscape

This earnings report follows the standard disclosure pattern mandated by the SEC periodic financial reporting requirements for publicly traded companies. It highlights the company's fiscal trajectory as it manages operational costs against shifting market demands.

These results provide insight into the financial health of the firm for investors and long-term stakeholders. The updated annual revenue forecast offers clarity regarding the company's performance expectations for the remainder of the 2026 fiscal year.

The takeaway

Quarterly earnings reports serve as a critical benchmark for stakeholders to evaluate corporate performance against internal and external projections. Investors often look for patterns in revenue consistency and adjusted EBITDA targets to determine the long-term viability of the company.